XML 29 R18.htm IDEA: XBRL DOCUMENT

SHARE CAPITAL AND STOCK OPTIONS (Tables)

3 Months Ended

Sep. 30, 2012

Stockholders Equity Note [Line Items]

	Three months ended September 30, 2012
	Number			Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (in years)		Aggregate Intrinsic Value Price
Options outstanding at beginning of period		2,082,172		$	3.87
Options exercised		(74,332	)		1.57
Options outstanding at end of the period		2,007,840		$	3.95		4.72	$	1,968
Options exercisable at the end of the period		2,007,840		$	3.95		4.72	$	1,968
Options vested		2,007,840		$	3.95		4.72	$	1,968

Schedule of Options and Warrants

	Three months ended September 30, 2012
	Number			Weighted Average Exercise Price		Weighted Average Remaining Contractual Terms (in years)		Aggregate Intrinsic Value Price
Options and warrants outstanding at beginning of period		382,000		$	3.86
Options and warrants exercised		(56,000	)		1.34
Options and warrants outstanding at end of the period		326,000		$	4.29		4.90	$	657

Options and warrants exercisable at the end of the period		314,000		$	4.46		4.75	$	609

Options and warrants vested		326,000		$	4.29		4.90	$	657

Schedule of Unvested Restricted Stock Units, Consultants

	Number
Unvested at the beginning of period		2,085,276
Granted		13,000
Forfeited		(37,213	)
Vested		(462,497	)
Unvested at the end of the period		1,598,566
Expected to vest after September 30, 2012		1,566,803

Schedule of Unvested Restricted Stock Units

Number
Unvested at the beginning of period	66,000
Granted	66,228
Vested	(76,728	)
Unvested at the end of the period	55,500
Expected to vest after September 30, 2012	55,500

Options and Warrants [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock-based Compensation Expenses Recognized

Three months ended September 30,
	2012		2011
Research and development expenses	$	-	$	10
General and administrative expenses		18		7
	$	18	$	17

Restricted Stock and Restricted Stock Units [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock-based Compensation Expenses Recognized

Three months ended September 30,
	2012		2011
Research and development expenses	$	317	$	253
General and administrative expenses		608		679
	$	925	$	932

Consultant Restricted Stock Units And Restricted Stock [Member]

Stockholders Equity Note [Line Items]

Schedule of Stock-based Compensation Expenses Recognized

Three months ended September 30,
	2012		2011
Research and development expenses	$	120	$	92
General and administrative expenses		273		-
	$	393	$	92

- Definition

Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.

+ References+ Details

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References+ Details